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Tile eleetrophysiological effects of N.aeetylaspart),iglutamate (NAAO), an endogenous peptide restrictiwly distributed in the central nervous 
system, were studied using Xenopua oocytes injected with RNAs transcribed from cloned glutamate r ceptor cDNAs. NAAG induced an inward 
current, dose dependently, in ooeyt¢~ inject "~xl with RNA for an N-meth~l.t>aspartate eceptor subunit (N MDAR I ). in contrast, he ooeytes injezted 
with RNAs for AMPA-sel¢¢tive glutamate r ceptors (GIuRI, GluR3, OluRI÷GIuR2 and GIuR2÷GIuR3) scarcely responded toNAAG, and the 
oocytes injected with RNA for kainate receptor (GIuR6) did not respond to NAAG. The half-maximal response (EDso) value of NAAG on expressed 
NMDARI was 185 ~M, which shows that NAAG is about 115-times less potent han L-glutamate (GIu), the EDso of which value was i.6/~M. 
The maximal current amplitude induced by NAAG was about 70% of that by Glu. NAAG-induced current in NMDAR I-injected oocyt¢~ was 
potentiated by glycine, dose-dependently antagonized by DL-2-amino-5-pbosphonovaleric cid, and blocked by magnesium ions in a voltage- 
dependent fashion. These results ttgBest that NAAG is one of the endogenous agonists selective for NMDARI. 
N-Acetylaspartylglutamat¢; NMDA receptor; AMPA-seleetivg glutamate r ceptor; Kainat¢ raeeptor; Xenopus oocyte; Agonist 
1. INTRODUCTION 
N-Acetylaspartylglutamate (NAAG)  is an en- 
dogenous peptide restrictively distributed in the central 
nervous system (CNS) [1-3]. In CNS, the content of 
NAAG is quite high, and almost similar to that of  ?- 
aminobutyric acid (GABA) [4]. NAAG has been re- 
ported to evoke electrophysiological excitatory effects 
in the neurons of  several brain regions [5-7], in cultured 
neuronal cells [8,9] and in Xenopus oocytes injected with 
cerebellar mRNA [10]. Since the excitatory effect of 
NAAG was suppressed by antagonists of  glutamate re- 
ceptors [6--9], it was suspected that NAAG was one of 
the endogenous agonists of  central glutamate receptors. 
Three kinds of  glutamate receptors have been suggested 
to mediate the excitatory effect o f  NAAG upon neu- 
rons; (i) N-methyl-D.aspartate (NMDA)  receptors [7- 
9], (it) quisqualate receptors (or ~z-amino-3-hydroxy-5- 
methyl-4-isoxazole propionic acid (AMPA)-selective 
glutamate receptors) [6] and (iii) 2-amino-4-phospho- 
nobutyric acid-selective receptors [5]. 
Recently, cDNAs encoding three subtypes o f  gluta- 
mate receptors, AMPA-seleetive glutamate receptors 
(GIuR1-4) [11-15], kainate receptors (GluR5-7) [16--18] 
and NMDA receptors (NMDARI  and NMDAR2A-  
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2C, or ~rl and e l -e3)  [19-23] were cloned. These clones 
were reported to form functional ligand-gated ion chan- 
nels when expressed in .Venopus ooeytes 
[11,12,14, i 5,17,19-21~23]. These findings have allowed 
us to study the effect of NAAG on each defined gluta- 
mate receptor subtype. 
In this study, we expressed AMPA-selective gluta- 
mate receptors (GIuRI-3), kainate receptor (GluR6) or 
NMDA receptor (NMDAR1)  in Xenopus ooeytcs by 
injecting RNAs transcribed from their cDNAs, and 
studied the selectivity of NAAG for each receptor sub- 
type. 
2. MATERIALS  AND METHODS 
2.1. Molecular biological experimettts 
The plasmid which carries eDNA for NMDAR! was kindly pro- 
vided by Dr. S. Nakanishi, Kyoto University, Kyoto, Japan. The 
plasmids which carry cDNAs for OluR I-3 and GIuR6 w~m a gift from 
Dr. S. Heinemann, Salk Institute, San Diego, USA. Each plasmid was 
purified by Csel--ethidium bromide ultracentrifugation, andthe puri- 
fied plusmid was lin~rized by an adequate r striction enzyme (New 
England Biochemieals), the recognition site of which was just down- 
stream of the eDNA insert (Nod for NMDARI, Xhol for GlaRI-3 
and Xbal for GIuR6). The linearized plasmid was treated with pro- 
teinase K for 30 rain at 37"C. In vitro transcription was carried oat 
by T7 or T3 RNA polymerase (Stmtagene) for NMDARI or for 
GIuRI-3 and GIuR6. rczlX~:tively, in the presence of a cap analog, 
5',7-methyl Gppp 5'G (Stratagene), for 30 min at 37"C. The DNA 
template was digested by DNA~¢ ! for 5 rain at 370C and the reaotion 
mixture was washed twi~ with a ,,fixture of phenol and chloroform 
(I :1). RNA transcripts were precipitated lay ettaanol and the precipi- 
tate was dissolved in distilled water. 
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Fig. 1. Electrophysiological ffcct of NAAG (N), Glu(G), NMDA(NM) and Kainate(K) upon oocytes injected with RNA transcribed from cDNA 
encoding NMDARI (A). AMPA-selective glutamate receptors (B-E) or kainatc receptor (F). In this and sulxquent hgures, [he downward and 
upward arrows indicate the initiation and termination of the application of rcagcnts, respectively, the dcnoled numhcrs are concentration (inhiM) 
of reagents, and the upward deflection indicates inward current. Glycine (IO ,uM) was added to a solution of NAAG, Glu and NMDA only in 
the case of A. All records except he insert in B, were obtained at a holding pOtCIItkdi or -70 mV; the record in the insert in 13 was obtained nt 
- I25 mV from a different aocytc in B. Vcrlical b:rr 25 nA for A and I;, 10 nA for 6 and 20 nA for C-E; horizontal bar 30 s for all. 
Oocytes were removed from Xcnoptrs kte~~is (Nasco) and treated 
with collagenase (3 mglml, Sigma Type la) with gentle agitation for 
2 h at room temperature in II Ca?+-free frog Ringers’ solution com- 
posed of 9G mM NaCI, 2 mM KCI, I mM MgC&. 5 mM HEPES (pH 
7.4). and 0.1 mM EGT.4. After 2 h, oocytes wcrc transferred to 
modified Barth’s medium (MBM) to wash out collapnase. The com- 
position of MBM was 38 mM NaCI. I mM KCI, 2.4 mM NaHCO?. 
I5 mM HEPES, 0.3 mM Ca(NO,),, 0.4 I mM CaCI,, 0.82 mM MgSO,,, 
lO~g/ml sodium penicillin and IO~gml streptomycin sulfate. Immedi. 
ately after this treatment. an oocyte was impaled with a glass micro- 
pipcttc filled with the RNA transcript solution and 50 t-11 each of the 
solution (400 ng of RNA per ~1) was injected. When two different 
RNA transcripts were injected, the transcripts were mixed prior to 
injection so that the final concentration of each RNA was 400 ng@. 
The oocytes were incubated for 3 days at IS-20°C in MBM. 
Three days after injccdon, an oocyte was transferred to the ccntcr 
of a round chamber, of diameter 7 mm and depth 3 mm (I IS brl in 
volume), and was continuously perfused at a flow rate of 0.5 mUmin 
with frog Ringers’ solution (I I5 mM NaCI, IO mM HEPES, 2 mM 
KC1 and 1.8 mM CaCI,, pH 7.2). Voltage-clamp recordings were 
carried out using AXOCLAMP-2A (Axon Instruments) by impaling 
two microclcctrodce filled with 3 M KCI. ant for voltage monitoring 
(input resistance was uboul IO MR) and the other for voltage clamping 
{about i MrGj. 
The Hill coefticient was obraincd a5 the slope of the regression line 
determined from the double-logarithm plots (log[concentration] vs. 
log{response/(maximel response-response)}). 
All drugs wcrc dissolved in frog Ringers’ solution and applied by 
perfusion. When the effxt of agonists on NMDARI-RNA-injected 
oocytes was investigated, glycine (IO PM) was added to the solutions 
of NAAG, Glu and NMDA unless otherwise specified. NAAG was 
dissolved into 50 ml frog Ringers’ solution at a concentration ol’ IO 
mM and the pH of the solution was adjusted IO 7.2 by several drops 
of 10 M NaOH. This soncentrated solution was stored at 4°C and 
diluted with frog Ringers’ solution for USC. Furthermore this solution 
wxs subjected to amino acid analysis (Peptide Technologies) to dctcr- 
mint the concentration of fret amino acid contaminants. 
NAAG, kaindrc and Glu were purchased from Sigma. tx-2-Amino- 
S~phosphonovaleric acid (APV) and NMDA were purchased from 
Cdmbridge Research Biochemicals, 
3. RESULTS 
3.1. Anulysis of the NAAG sample 
No peak of free Glu and aspartate was detected in the 
10 mM NAAG sample used in the electrophysiological 
study. The detection limit of the amino acid analyzer 
used was 5-10 prnol. and 20 ~1 of 10 mM NAAG solu- 
tion was assayed. Therefore, the maximum concentra- 
tion of Glu contaminating the 10 mM NAAG sample 
is 500 nM and the maximum Glu concentration in the 
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500 PM NAAG solution used for electrophysiology is
25 nM. 
3.2. Elcclrophysiology 
At a holding potential of -70 mV, an inward current 80 - 
was elicited by NAAG in all the oocytes injected with t 
the RNA transcript for NMDARl (Fig. 1A). As shown 
fi 80- 
in Fig. 1 A, the current response by NAAG resembled & 
that of Glu or NMDA. Little or no current was ob- 
2 40- 
served after the application of NAAG (up to I mM) in @ 20- 
the uninjected control oocytes (data not shown). 500 O- 
,uLM NAAG induced inward currents in the oocytes, 
while 50 nM Glu, which was 2-times higher than the I 
NlOOOJ 
-*Ok* ‘7 ‘c ‘c ‘A ‘0 
maximum concentration expected to contaminate the 
500,uM NAAG solution, induced no inward current in 
the same oocytes (Fig. 1A). 
Because the lowest concentration of NAAG, Glu and 
NMDA inducing maximal current amplitude in 
NMDARl-RNA-injected oocytes was determined to 
be about 500 ,uM, 10 ,uM (Fig. 2) and 200 PM (unpub- 
lished observation), respectively, the potency of the 
three agonists to open the channel formed by 
NMDARl receptors was compared by using each ag- 
onist at this concentration. As shown in Fig. 1A and 
summarized in Table I, the potency of NAAG was 
weaker than that of Glu and NMDA. The mean current 
amplitude induced by 500 ,uM NAAG, 10 AM Glu and 
200 ,uM NMDA in the presence of 10 ,uM glycine at the 
holding potential of -70 mV was 30 2 5, 40 f 8 and 
35 f 8 nA, respectively, in NMDARI-RNA-injected 
oocytes, as shown in Table I. 
log[agonist (M)] 
Fig. 3. Dose-response curves for NAAG (open circles) and Glu 
(closed circles) in oocytcs injected with RNA for NMDARI. NAAG 
and 6lu (IO PM glycine was added) were applied at the various 
concentrations a  illustrnted in the inserts (N, NAAG; G, Glu; vertical 
bar 35 I-IA; horizontal bar 20 s), and the amplitude ofeach current was 
normalized as the fraction of maximal current (the current obtained 
at I mM ror NAAG (30 ZL 4 nA) aud at IOOpM for Glu (35 f 5 nA)). 
Each point represents the mean f S.E.M of 4-6 experiments. At the 
points where the error bar is not indicated, S.E.M. is smaller than the 
symbol. For other symbols et Fig. 1. 
In contrast, as shown in Fig. l&F, NAAG (5OOkM) 
scarcely induced an electrophysiological response in the 
oocytes injected with RNA for AMPA-selective gluta- 
mate receptors (Fig. lB-E) or for kainate receptors 
(Fig. 1 F), at the holding potential of -70 mV, while Glu 
Table I 
Amplitude of the current induced by NAAG, Glu, NMDA and kainate in oocytcs injected with RNA for various 
ulutamate recetnors 
RNA injected Agonist-evoked current (nA) 
Kainate Glu NMDA NAAG 
NMDARI 40 z!I 8 (100) 35 t a (84) 30 + 5 (78) 
W) W) W/6) 
GIURI 41 + 7 (431)’ 10~4(100) I -t- I(l6) 
(6/(i)“* (W (W 
GluR3 66 r 9 (1,434) 5 f I (100) 0 f 0 (0) 
(95) (515) (O/5) 
GluRl t GluR2 103 + I1 (1,30(i) 10 f 3 (loo) 3 f I (13) 
(414) (414) - (314) 
GluR?. + GluR3 140 ?: 31 (1,455) 10 f 2 (100) 2 +- 2 (IS) 
(4/4) (414) (34) 
GluR6 34 -r- 7(198) I7 + 3 (100) 0 r!C 0 (0) 
(313) (313) (O/3) 
Inward currents induced by kainate( IOOPM), glutamatc(lO~M lbrNMDAR1 and IOOpM for others), NMDA 
(300 ,uM) and NAAG (500 PM) were recorded at -70 mV in the oocytes injected with the RNAs for various 
glutamate receptors. Glycinc (10 PM) was added to the agonists olution only in the case of NMDARI. 
Agonist-evoked current is represcntcd as the mean & S.E.M. in nA. 
*Relative responses, representing the relative value of each response when the Glu responx is standardized as 
?&mber of oocytcs responding/number of oocytes tested 
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Fig. 3. Properties of NAAG-induced current in the oocytes injected 
with RNA for NMDARI. (A) Effect of removing of glycine on 
NAAG (N, 500 PM)-induced current. (B) Effect of APV (10 and 70 
PM) on NAAG (500 bM)-indcccd currznt. Vertical bar 15 nA; hori- 
zontal bar 20 s. (C) Current-voltage r lationship of NAAG-induced 
current in tbc absence (closed circles) and presence (open circles) of 
1OOpM M#&. The inserts were sample records at - I.50 and -30 mV. 
Vertical bar 20 nA; horizontal bar 30 s. 
(100 ,uM) or kainate (100 FM) induced an inward cur- 
rent in these oocytes. In homomeric AMPA-selective 
glutamate receptors, only 2 out of G oocytcs injected 
with RNA for GluRl responded to NAAG with a cur- 
rent smaller than 4 nA (Fig. LB and Table I), and no 
detectable current was observed in the remaining 4 
oocytes even at a membrane potential of -125 mV, as 
shown in the Fig. IB insert. Furthermore, in the case of 
the oocytes injected with RNA for GluR3, no detectable 
current was induced by NAAG in all 5 oocytes tested 
(Fig. 1C and Table I). In hetcromeric AMPA-selective 
glutamate receptors, 3 out of 4 oocytes or 2 out of 4 
oocytes injected with a RNA mixture of GluRl and 
GluR2 (Fig. 1D and Table I) or Glu R2 and GluR3 
(Fig. 1E and Table I), respectively, responded to 
NAAG with a current smaller than 5 nA, and the other 
oocytes did not respond to NAAG. On the other hand, 
for the kainate receptor (GluR6, Fig. 1F and Table I), 
no detectable current was observed after the application 
of NAAG. The mean amplitudes, including those of 
non-responsive oocytes, and relative responses at the 
holding potential of -70 mV are summarized in 
Table I. 
Fig. 2 shows the dose-response curve of NAAG 
(open circles) and Glu (closed circles) for NMDARI- 
injected oocyles and the inserts are the sample records 
(G, Glu; N, NAAG; PM) As illustrated in Fig. 2, the 
inward current induced by NAAG and Glu in 
NMDAR 1 -injected oocytes was dose dependent, and 
the apparent half-maximal response (ED,,) value was 
185 and 1.6 PM for NAAG and Glu, respectively. The 
EDso value for Glu is slightly higher than the reported 
value [19]. The Hill coefficient calculated from these 
data is 1.7 for Glu and 1.0 for NAAG. 
Fig. 3 shows the properties of an NAAG-induced 
current in the oocytes injected with RNA for 
NMDAR 1. The NAAG-induced current was reduced 
by removing glycine (Fig. 3A, -Gly) and was antago- 
nized, dose dependently, by APV (Fig. 3B). Fig. 3C is 
the current- voltage relationship of the NAAG-induced 
current in the absence (closed circles) and the presence 
(open circles) of 100 PM Mg”, and the inserts are the 
sample records. As shown in Fig. 3C, the NAAG-in- 
duced current was blocked by Mg” in a voltage-de- 
pendent manner. 
4. DISCUSSION 
We demonstrate in the present study that Xenopus 
oocytes injected with RNA for NMDARl respond to 
NAAG electrophysiologically, while the response to 
NAAG of oocytes injected with RNAs for AMPA-se- 
lective glutamate receptors or kainate receptors was 
very low or absent, respectively. 
Because a 2-times higher concentration of Glu than 
that of the maximal contamination of Glu in the NAAG 
sample used induced no response in NMDARI-RNA- 
injected oocytes, it is unlikely that the NAAG-induced 
current is due to Glu present in the NAAG sample. It 
is possible that the NAAG which is applied to oocytes 
might be quickly hydrolyzed I;y peptidases on the sur- 
face of oocytes and that the Glu produced through this 
procedure might activate NMDARl, but this possibil- 
ity appears unlikely because NAAG induced an inward 
current at a latency as short as that induced by Glu (Fig. 
LA). The fact that NAAG and Glu have different Mill 
coefficients also provides evidence that the effect of 
NAAG was due to NAAG itself. 
NAAG has been reported to activate NMDA recep- 
tors in neurons [7-g]. Results of the present study pro- 
vide further confirmation of the previous reports. The 
present study also indicates that NAAG induces the 
typical response licited by NMDA receptors: potentia- 
tion by glycine [24,25], suppression by APV [26] and 
voltage-dependent blockade by Mg?” [27,28]. Further- 
more, it was found that NAAG scarcely activated 
AMPA-selective glutamate receptors a?2d id not acti- 
vate kainate receptors. These basic properties of NAAG 
upon glutamate receptors will be helpful to address the 
physiological role of NAAG in the CNS. 
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